Key Market Indicators
Sales of diabetes medicine in Finland are expected to reach around $240 million by 2026, up from $214 million in 2021. Comparatively, the market has seen an average growth of 4.7% year-on-year since 2003, however Denmark overtook Finland as the 16th largest market in 2021. Canada, Spain and Italy ranked second, third and fourth respectively. Finnish insulin imports are expected to reach around $94 million in 2026, up 0.9% year-on-year from $90 million in 2021. Since 1993, the demand for insulin in Finland has fallen by 0.6% year-on-year. Insulin exports from Finland are expected to reach around $4.9 million in 2018, down 95.9% from $202 million in 2017. Finland ranked 40th in 2018, behind Chile. France, Italy and China ranked second, third and fourth respectively.
